Knee Arthroplasty
Conditions
Keywords
physical activity
Brief summary
The purpose is to examine the effects of an online physical activity program on moderate to vigorous intensity physical activity, pain, and physical function in adults with knee replacement at 3 months (post-intervention) and 6 months (maintenance).
Detailed description
Participants with knee replacement will be randomized to start the online physical activity program (Energize!) either immediately or after 3 months. The online program consists of weekly physical activity goals, video lessons, action planning, and homework to help increase physical activity to 200 min/week. Assessments will be completed at baseline, 3 months, and 6 months.
Interventions
Energize! is 3 month online physical activity program which consists of weekly physical activity goals, video lessons, action planning, and homework.
Sponsors
Study design
Eligibility
Inclusion criteria
* Have had a partial or total knee replacement ≥12 months ago * Have regular access to the internet * Willing to wear activity monitor for 7 days at baseline, 3 \& 6 months * Engage in less than 60 minutes of self-reported moderate intensity exercise
Exclusion criteria
* Have a mobility limiting comorbidity * Non-English speaking * Have a scheduled surgery within the next 6 months that would limit activity
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Minutes of Moderate to Vigorous Intensity Physical Activity | baseline to 3 months | Minutes of moderate to vigorous intensity physical activity assessed by Actigraph accelerometers |
| Pain Intensity | baseline to 3 months | Pain intensity assessed by Patient-Reported Outcomes Measurement Information System pain intensity survey. 0 represents no pain and 10 reports the most severe pain |
| Self-reported Physical Function | baseline to 3 months | Physical function assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) physical function/mobility survey. A t-score of 0 represents poor function compared to average and 100 represents better function. A t-score of 50 indicates the population mean with a standard deviation of 10. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Minutes/Week of Moderate to Vigorous Intensity Physical Activity | 3 months to 6 months | Minutes of moderate to vigorous intensity physical activity assessed by Actigraph accelerometers worn on the waist for 7 days |
| Pain Intensity | 3 months to 6 months | Pain intensity assessed by Patient-Reported Outcomes Measurement Information System pain intensity survey. 0 represents no pain and 10 reports the most severe pain |
| Self-reported Physical Function | 3 months to 6 months | Physical function assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) physical function/mobility survey. A t-score of 0 represents poor function compared to average and 100 represents better function. A t-score of 50 indicates the population mean with a standard deviation of 10. |
Countries
United States
Baseline characteristics
| Characteristic | — |
|---|---|
| Actigraph assessed moderate-vigorous intensity physical activity | 54.0 minutes/week STANDARD_DEVIATION 61.3 |
| Age, Continuous | 68.0 years STANDARD_DEVIATION 6.8 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 23 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 2 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 46 Participants |
| Sex: Female, Male Female | 40 Participants |
| Sex: Female, Male Male | 4 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 27 | 0 / 23 |
| other Total, other adverse events | 8 / 27 | 6 / 23 |
| serious Total, serious adverse events | 2 / 27 | 0 / 23 |